Abstract
The COVID-19 pandemic has significantly impacted human health for three years. To mitigate the spread of SARS-CoV-2, the development of neutralizing antibodies has been accelerated, including the exploration of alternative antibody formats such as single-domain antibodies. In this study, we identified variable new antigen receptors (VNARs) specific for the receptor binding domain (RBD) of SARS-CoV-2 by immunizing a banded houndshark (Triakis scyllium) with recombinant wild-type RBD. Notably, the CoV2NAR-1 clone showed high binding affinities in the nanomolar range to various RBDs and demonstrated neutralizing activity against SARS-CoV-2 pseudoviruses. These results highlight the potential of the banded houndshark as an animal model for the development of VNAR-based therapeutics or diagnostics against future pandemics.
| Original language | English |
|---|---|
| Article number | 108807 |
| Journal | Fish and Shellfish Immunology |
| Volume | 138 |
| DOIs | |
| State | Published - Jul 2023 |
Keywords
- Banded houndshark (Triakis scyllium)
- COVID-19
- Phage display immune library
- SARS-CoV-2
- Single domain antibody
- Variable new antigen receptor (VNAR)